Chemoprevention of Colonic Polyps with Balsalazide: An Exploratory, Double-Blind, Placebo-Controlled Study
Open Access
- 11 September 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 54 (11), 2488-2496
- https://doi.org/10.1007/s10620-009-0966-2
Abstract
A number of agents, including aspirin, nonsteroidal antiinflammatory drugs, cyclooxygenase-2 inhibitors, folic acid, calcium, and vitamins, have been evaluated for their potential in chemoprevention of sporadic colorectal adenomas or cancer. Preclinical data suggest that 5-aminosalicylates also may have a chemopreventive effect. To investigate chemoprevention of colonic polyps with balsalazide, a 5-aminosalicylate prodrug. In this randomized, double-blind, placebo-controlled study, adults diagnosed with small polyps in the rectosigmoid colon were treated with either balsalazide 3 g/d or placebo for 6 months. Follow-up lower endoscopy was performed, and all polyps were measured and analyzed histologically. The primary endpoint was reduction in mean size of the largest polyp per subject. Among 241 participants screened, 86 were randomized to treatment, with 75 subjects evaluable. Balsalazide 3 g/d (n = 38) did not significantly reduce the mean size of the largest colonic polyp or the number of polyps compared with placebo (n = 37). Although not significant, post-hoc analysis revealed that total adenoma burden per subject, calculated as the sum of the volumes of all adenomas in mm3, increased by 55% in the balsalazide group compared with 95% in the placebo group. Although balsalazide did not have significant chemopreventive effects on established colonic polyps, these results can aid in designing future prospective studies.Keywords
This publication has 34 references indexed in Scilit:
- Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal TumorsGastroenterology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- 5-ASA Affects Cell Cycle Progression in Colorectal Cells by Reversibly Activating a Replication CheckpointGastroenterology, 2007
- Mesalazine Improves Replication Fidelity in Cultured Colorectal CellsCancer Research, 2005
- Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γThe Journal of Experimental Medicine, 2005
- Colorectal cancer chemoprevention—an overview of the scienceGastroenterology, 2004
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitisGastroenterology, 1998
- CHEMOPREVENTION OF COLORECTAL CANCERGastroenterology Clinics of North America, 1996
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992